FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for Sandoz to market a generic mycophenolate mofetil, an immunosuppressant used to prevent organ transplant rejectio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection Prophylaxis
• Kidney Transplant Rejection Prophylaxis
• Liver Transplant Rejection Prophylaxis
• Organ Transplant Rejection Prophylaxis

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)